BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18845836)

  • 1. CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection.
    Cocco M; Bellan C; Tussiwand R; Corti D; Traggiai E; Lazzi S; Mannucci S; Bronz L; Palummo N; Ginanneschi C; Tosi P; Lanzavecchia A; Manz MG; Leoncini L
    Am J Pathol; 2008 Nov; 173(5):1369-78. PubMed ID: 18845836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.
    Baenziger S; Tussiwand R; Schlaepfer E; Mazzucchelli L; Heikenwalder M; Kurrer MO; Behnke S; Frey J; Oxenius A; Joller H; Aguzzi A; Manz MG; Speck RF
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15951-6. PubMed ID: 17038503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro Epstein-Barr virus infection model of rabbit lymphocytes from peripheral blood or spleen.
    Kanai K; Kato K; Sano H; Nagata K; Okuno K; Kuwamoto S; Higaki H; Sugihara H; Kato M; Murakami I; Hayashi K
    Intervirology; 2011; 54(1):17-24. PubMed ID: 20689312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
    Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
    Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus.
    Cavalcante P; Serafini B; Rosicarelli B; Maggi L; Barberis M; Antozzi C; Berrih-Aknin S; Bernasconi P; Aloisi F; Mantegazza R
    Ann Neurol; 2010 Jun; 67(6):726-38. PubMed ID: 20517934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.
    Choi BK; Joo SY; Moon C; Park KS; Kim SH; Park JB; Jung GO; Choi GS; Kwon CH; Chun JM; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2008 Oct; 40(8):2655-60. PubMed ID: 18929829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a human adaptive immune system in cord blood cell-transplanted mice.
    Traggiai E; Chicha L; Mazzucchelli L; Bronz L; Piffaretti JC; Lanzavecchia A; Manz MG
    Science; 2004 Apr; 304(5667):104-7. PubMed ID: 15064419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
    Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
    Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
    Guerreiro M; Na IK; Letsch A; Haase D; Bauer S; Meisel C; Roemhild A; Reinke P; Volk HD; Scheibenbogen C
    Eur J Immunol; 2010 Jun; 40(6):1566-76. PubMed ID: 20232341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T; Yachie A; Kanegane H; Kimura H; Shiobara S; Nakao S
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G; Agathanggelou A; Herbst H; Whitehead L; Wright DH; Young LS
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
    Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
    J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.